Snowball logo
logo
APPH

Apontis Pharma AG

€11.00€0.00  (0%)
Estimate
P/E
137.5
EPS
0.08
Beta
1.16
Forecast
P/E (FWD)
15.3
EPS (FWD)
0.72
About the company
Ticker
APPH
ISIN
DE000A3CMGM5
Country
Germany
Sector (GICS)
Healthcare
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, dylipidemia, secondary prophylaxis, and asthma, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Frequently asked questions

What sector does Apontis Pharma AG (APPH) operate in?

Apontis Pharma AG belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Apontis Pharma AG (APPH) current stock price?

As of the latest data, Apontis Pharma AG stock price is €11.00, with a previous close of €11.00.

What is Apontis Pharma AG (APPH) current market capitalization?

Apontis Pharma AG market cap is approximately 91.63 million.

What is Apontis Pharma AG (APPH) Earnings Per Share (EPS)?

The trailing EPS is €0.08, and the forward EPS is €0.72.

What is Apontis Pharma AG (APPH) Price-to-Earnings (P/E) ratio?

Apontis Pharma AG current P/E ratio is 137.5, with a forward P/E of 15.28.

Does Apontis Pharma AG (APPH) pay dividends?

No. Apontis Pharma AG does not pay a dividend.

What is Apontis Pharma AG (APPH) beta (volatility) score?

Apontis Pharma AG has a beta of 1.160, meaning its volatility is roughly in line with the market.